Abstract��OBJECTIVE To analyze the actual dosages of chloral hydrate solution used in pediatric patients in our hospital and discuss how to prevent excessive dosing or accumulated overdose.METHODS The prescriptions of chloral hydrate solution for outpatients under or equal to 18 years old during the period of July 2015 to December 2015 in our hospital were extracted.The information about departments,patient age,and dosages were collected. The dose ranges of chloral hydrate according to the height and weight standardized growth charts for children were calculated in order to determine whether the prescribed dosage was too high and whether there was risk of overuse and cumulative overdose.RESULTS A total of 1 086 chloral hydrate prescriptions were extracted, mostly prescribed by the departments of neurology, pediatrics, ENT and other departments for sedation before examinations.The children under or equal to 12 years old were mostly prescribed 10 mL of chloral hydrate solution, while those over 13 years old were prescribed 30 mL. The risk of overdose was 12.8%.The actual dosages were too small for some children. There existed drug waste phenomenon and potential risks of accidental medication and overuse.There were 12 patients with repeated prescriptionson the same day, resulting in a repeated medication risk.CONCLUSION In order to avoid the risk of overdose and repeated use of chloral hydrate solution in pediatric children,it is necessary to comply with the high-risk drug management system, improve the hospital information system,write prescriptions correctly, and change the preparation package of chloral hydrate solution.Pharmacists need to play a more active role.
��, �����, ����, ��ٻٻ. ��Ժ��ͯʹ��ˮ����ȩ��Һ�IJ������������շ��������[J]. �й�ҩѧ��־, 2017, 52(3): 249-252.
KONG Jian, YANG Gen-zhi, ZHU Zhu, FAN Qian-qian. Risk Analysis and Management of Use of Chloral Hydrate Solution in Pediatric Patients in Our Hospital. Chinese Pharmaceutical Journal, 2017, 52(3): 249-252.
CHEN X Q, JIN Y Y, TANG G. Pharmacology(�±�ҩ��ѧ)[M]. 17th. Beijing:People's Medical Publishing House, 2011:231.
[2]
LI D K, JIN Y Y, TANG G, et al. Martindale The Complete Drug Reference(������ҩ����)[M]. Beijing:Chemical Industry Press, 2009:950951.
[3]
HU Y M, JIANG Z F, SHEN K L, et al. Zhu Futang Textbook of Pediatrics(���ʵ�ö���ѧ)[M]. 8th. Ed, Beijing:People's Medical Publishing House, 2015:4654.
[4]
LING Y, LIU Y, SHI Q, et al. Apnea in a neonate due to mistaken high-dose chloral hydrate[J]. Adv Drug React J(ҩ�ﲻ����Ӧ��־), 2015, 17(5):395-396.
[5]
CAO Y, XING Y, ZHENG C. Literature analysis of 18 cases of adverse reactions induced by chloral hydrate[J]. Chin J Pharmacov(�й�ҩ�ﾯ��), 2013, 10(11):687-689.
[6]
Institute for Safe Medication Practices. ISMP list of high-alert medications in acute care settings[EB/OL]. [2016-01-12]. http://www. ismp. org/tools/institutionalhighAlert. asp.
[7]
Chinese pharmaceutical association committee of hospital pharmacy, Drug safety project team. High-risk drug classification management strategy and recommended directory[EB/OL]. [2016-6-20]. http://www. cpahp. org. cn/ccyyf/news/201203/1435. htm.
[8]
HUA X D, FANG H M, MA K, et al. The application of information technology in highrisk drug management[J]. Chin Pharm J(�й�ҩѧ��־), 2013, 46(4):313-314.
[9]
WANG Q, REN X Y. Sleep deprivation method in infants chloral hydrate calm analysis of application effect[J]. J Nurses Training(��ʿ������־),2010, 25(16):1491-1492.
[10]
SUN L, LIU S X. Effect of reasonable induction for chloral hydrate sedation for infants[J]. Chin Nur Res(�����о�), 2013, 27(3):820-821.
2017, Vol. 52 
